BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15476236)

  • 1. Enhanced interleukin-1beta and interleukin-18 release in a patient with chronic infantile neurologic, cutaneous, articular syndrome.
    Janssen R; Verhard E; Lankester A; Ten Cate R; van Dissel JT
    Arthritis Rheum; 2004 Oct; 50(10):3329-33. PubMed ID: 15476236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations.
    Gattorno M; Tassi S; Carta S; Delfino L; Ferlito F; Pelagatti MA; D'Osualdo A; Buoncompagni A; Alpigiani MG; Alessio M; Martini A; Rubartelli A
    Arthritis Rheum; 2007 Sep; 56(9):3138-48. PubMed ID: 17763411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic mosaicism of CIAS1 in a patient with chronic infantile neurologic, cutaneous, articular syndrome.
    Saito M; Fujisawa A; Nishikomori R; Kambe N; Nakata-Hizume M; Yoshimoto M; Ohmori K; Okafuji I; Yoshioka T; Kusunoki T; Miyachi Y; Heike T; Nakahata T
    Arthritis Rheum; 2005 Nov; 52(11):3579-85. PubMed ID: 16255047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variant chronic infantile neurologic, cutaneous, articular syndrome due to a mutation within the leucine-rich repeat domain of CIAS1.
    Frenkel J; van Kempen MJ; Kuis W; van Amstel HK
    Arthritis Rheum; 2004 Aug; 50(8):2719-20. PubMed ID: 15334500
    [No Abstract]   [Full Text] [Related]  

  • 5. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases.
    Aksentijevich I; Nowak M; Mallah M; Chae JJ; Watford WT; Hofmann SR; Stein L; Russo R; Goldsmith D; Dent P; Rosenberg HF; Austin F; Remmers EF; Balow JE; Rosenzweig S; Komarow H; Shoham NG; Wood G; Jones J; Mangra N; Carrero H; Adams BS; Moore TL; Schikler K; Hoffman H; Lovell DJ; Lipnick R; Barron K; O'Shea JJ; Kastner DL; Goldbach-Mansky R
    Arthritis Rheum; 2002 Dec; 46(12):3340-8. PubMed ID: 12483741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Good response to IL-1beta blockade by anakinra in a 23-year-old CINCA/NOMID patient without mutations in the CIAS1 gene. Cytokine profiles and functional studies.
    Hedrich CM; Fiebig B; Sallmann S; Bruck N; Hahn G; Roesler J; Roesen-Wolff A; Heubner G; Gahr M
    Scand J Rheumatol; 2008; 37(5):385-9. PubMed ID: 18609262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes.
    Feldmann J; Prieur AM; Quartier P; Berquin P; Certain S; Cortis E; Teillac-Hamel D; Fischer A; de Saint Basile G
    Am J Hum Genet; 2002 Jul; 71(1):198-203. PubMed ID: 12032915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and genetic characterization of Italian patients affected by CINCA syndrome.
    Caroli F; Pontillo A; D'Osualdo A; Travan L; Ceccherini I; Crovella S; Alessio M; Stabile A; Gattorno M; Tommasini A; Martini A; Lepore L
    Rheumatology (Oxford); 2007 Mar; 46(3):473-8. PubMed ID: 16920754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model.
    Aksentijevich I; Putnam CD; Remmers EF; Mueller JL; Le J; Kolodner RD; Moak Z; Chuang M; Austin F; Goldbach-Mansky R; Hoffman HM; Kastner DL
    Arthritis Rheum; 2007 Apr; 56(4):1273-1285. PubMed ID: 17393462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal treatment of CINCA syndrome.
    Paccaud Y; Berthet G; Von Scheven-Gête A; Vaudaux B; Mivelaz Y; Hofer M; Roth-Kleiner M
    Pediatr Rheumatol Online J; 2014; 12():52. PubMed ID: 25584041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonclassic neurologic features in cryopyrin-associated periodic syndromes.
    Ting TV; Scalzi LV; Hashkes PJ
    Pediatr Neurol; 2007 May; 36(5):338-41. PubMed ID: 17509468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CINCA Syndrome.
    Khemani C; Khubchandani R
    Indian Pediatr; 2007 Dec; 44(12):933-6. PubMed ID: 18175851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Exacerbation of skin lesions during fever in a patient with chronic infantile neurologic cutaneous articular (CINCA) syndrome].
    Aboín-González S; Aldanondo-Fernández de la Mora I; García-Acebes CR; Carrillo-Gijón R; Harto-Castaño A; Jaén-Olasolo P
    Actas Dermosifiliogr; 2008; 99(6):481-4. PubMed ID: 18558058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU.
    Neven B; Callebaut I; Prieur AM; Feldmann J; Bodemer C; Lepore L; Derfalvi B; Benjaponpitak S; Vesely R; Sauvain MJ; Oertle S; Allen R; Morgan G; Borkhardt A; Hill C; Gardner-Medwin J; Fischer A; de Saint Basile G
    Blood; 2004 Apr; 103(7):2809-15. PubMed ID: 14630794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A severe case of chronic infantile neurologic, cutaneous, articular syndrome treated with biologic agents.
    Matsubara T; Hasegawa M; Shiraishi M; Hoffman HM; Ichiyama T; Tanaka T; Ueda H; Ishihara T; Furukawa S
    Arthritis Rheum; 2006 Jul; 54(7):2314-20. PubMed ID: 16802372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3.
    Kanneganti TD; Ozören N; Body-Malapel M; Amer A; Park JH; Franchi L; Whitfield J; Barchet W; Colonna M; Vandenabeele P; Bertin J; Coyle A; Grant EP; Akira S; Núñez G
    Nature; 2006 Mar; 440(7081):233-6. PubMed ID: 16407888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrafamilial variable phenotypic expression of a CIAS1 mutation: from Muckle-Wells to chronic infantile neurological cutaneous and articular syndrome.
    Hentgen V; Despert V; Leprêtre AC; Cuisset L; Chevrant-Breton J; Jégo P; Chalès G; Gall EL; Delpech M; Grateau G
    J Rheumatol; 2005 Apr; 32(4):747-51. PubMed ID: 15801036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra.
    Hawkins PN; Lachmann HJ; Aganna E; McDermott MF
    Arthritis Rheum; 2004 Feb; 50(2):607-12. PubMed ID: 14872505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A somatic NLRP3 mutation as a cause of a sporadic case of chronic infantile neurologic, cutaneous, articular syndrome/neonatal-onset multisystem inflammatory disease: Novel evidence of the role of low-level mosaicism as the pathophysiologic mechanism underlying mendelian inherited diseases.
    Aróstegui JI; Lopez Saldaña MD; Pascal M; Clemente D; Aymerich M; Balaguer F; Goel A; Fournier del Castillo C; Rius J; Plaza S; López Robledillo JC; Juan M; Ibañez M; Yagüe J
    Arthritis Rheum; 2010 Apr; 62(4):1158-66. PubMed ID: 20131270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed reactivation of chronic infantile neurologic, cutaneous, articular syndrome (CINCA) in a patient with somatic mosaicism of CIAS1/NLRP3 gene after withdrawal of anti-IL-1 beta therapy.
    Paloni G; Pastore S; Tommasini A; Lepore L; Taddio A
    Clin Exp Rheumatol; 2015; 33(5):766. PubMed ID: 26316056
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.